{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/0006-5083#drug","name":"KEYTRUDA QLEX","alternateName":"pembrolizumab and berahyaluronidase alfa-pmph","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"0006-5083"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"BLA761467"},{"@type":"PropertyValue","propertyID":"UNII","value":"DPT0O3T46P|9X4R4A4HQQ"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"097d166f-b73b-41d3-9b37-7653cd2a0c41"}],"activeIngredient":"BERAHYALURONIDASE ALFA, PEMBROLIZUMAB","administrationRoute":["SUBCUTANEOUS"],"dosageForm":"INJECTION, SOLUTION","manufacturer":{"@type":"Organization","name":"Merck Sharp & Dohme LLC"},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/BLA761467","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=097d166f-b73b-41d3-9b37-7653cd2a0c41","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0006-5083"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-01T01:04:55.771Z"}}